Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The intravenous (IV) fluid bags market was valued at USD 2.78 Billion in 2025 and is expected to grow at a CAGR of 9.62%, reaching USD 6.97 Billion by 2035. The market growth is driven by rising hospital admissions, expanding surgical procedures, and increasing demand during emergencies and disasters.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
9.62%
Value in USD Billion
2026-2035
*this image is indicative*
An intravenous (IV) fluid bag refers to a sterile bag which stores fluids, such as medicines, chemicals, or blood, that are intended to be injected in a patient’s body intravenously. These bags ensure timely and efficient delivery of larger volumes of medical fluids while protecting the contents from contamination. Intravenous (IV) fluid bags are usually made up of polyvinyl chloride (PVC).
The growing prevalence of chronic conditions such as cancer, tuberculosis, and diabetes, among others, is posing as an opportunity for the market by generating a significant demand for IV fluids. The anticipated increase in demand for more convenient options such as the disposable IV fluid bags, which reduce the cross-contamination while saving hospitals or clinic costs, is anticipated to add to the intravenous (IV) fluid bags market growth in the forecast period. Increasing investments by the households towards home care settings are further expanding the market opportunities, owing to the fact that intravenous (IV) fluid bags can be used anywhere without any hassle.
However, the anticipated increase in the transition towards oral administration of fluids, owing to the changing patient preference towards minimally invasive treatment procedures is anticipated to pose as a challenge in the global intravenous (IV) fluid bags market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR’s report titled “Intravenous (IV) Fluid Bags Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Fluid Type
Market Breakup by Application
Market Breakup by End-User
Market Breakup by Region
The normal saline segment, based on fluid type, accounts for a healthy share of the intravenous (IV) fluid bags market. Normal saline is a type of fluid which is used to treat conditions such as dehydration, metabolic alkalosis, and hypovolemia, among others. Hence, the increasing hospitalisation rates, induced by the sedentary lifestyles led by a growing number of people, is propelling the demand for normal saline which is in turn is fuelling the IV fluid bags market. Meanwhile, dextrose is likely to witness a heightened demand due to the increasing prevalence of low blood sugar.
Regionally, North America accounts for a significant share in the market due to the well-established healthcare infrastructure in countries in the region as well as steady supply of IV fluid bags. The growing popularity of intravenous vitamin therapy to treat chronic conditions such as asthma attacks, migraines, and fibromyalgia, among others is further supporting the market growth in the region. Easy accessibility and early adoption of new types of IV bags is likely to bolster market growth over the coming years. The Asia Pacific is also expected to offer lucrative opportunities to the intravenous (IV) fluid bags market owing to the rapid urbanisation and robust growth of local clinics and hospitals.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Baxter International, Inc. is a leading healthcare company which provides high grade products and services to cater to the healthcare demands across the world. The company innovates in kidney care, scientific exchange, and various types of therapies. Baxter International, Inc. was founded in the year 1931 and is currently headquartered in Illinois, United States.
B. Braun Medical Inc. is a leading producer, manufacturer, marketer, and innovator of medical products. The company providers general purpose IV solutions, dextrose injections, products related to fluid therapy and injectable drugs, and fluid bags which are utilised across various healthcare units. B. Braun Medical Inc. was established in 1839 and is currently headquartered in Pennsylvania, United States.
Fresenius Kabi AG is a renowned pharmaceutical company which produces lifesaving medicines and technologies aimed towards carrying out infusions, transfusions, and clinical nutrition. The product portfolio of Fresenius Kabi AG includes innovative IV solutions such as Freeflex and Freeflex+, among others. It was founded in 1999 and is headquartered in Bad Homburg, Germany.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Becton, Dickinson and Company, and ICU Medical, Inc., among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is estimated to grow at a CAGR of 9.62% in the forecast period of 2026-2035.
The increasing demand for intravenous (IV) fluid bags for safe and risk-free administration of IV fluids, rising prevalence of dehydration and acid base imbalance among the adult and geriatric population, and increasing standards of healthcare infrastructure are the major drivers of the market.
The key trends in the market include the growing innovations leading to the development of more convenient options such as disposable IV fluid bags and increasing popularity of intravenous vitamin therapy.
Normal saline, dextrose, ringer’s lactate, and vitamins, among others, are the different fluid types in the market.
Clinical and wellness are the primary application of intravenous (IV) fluid bags in the market. Wellness is further divided based on wellness type into immunity, hangover treatment, and athletic performance improvement, among others.
An intravenous (IV) fluid bag is used for storing IV fluids to ensure proper administration of IV fluids into the patient.
The major regional markets for intravenous (IV) fluid bags, according to the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Hospitals, hydration centres/clinics, and home care settings, among others, are the different end-users of IV fluid bags in the market.
Baxter International, Inc., B. Braun Medical Inc., Fresenius Kabi AG, Becton, Dickinson and Company, and ICU Medical, Inc., among others, are the key players of the global intravenous (IV) fluid bags market, according to the report.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Fluid Type |
|
| Breakup by Application |
|
| Breakup by End-User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share